These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 31401441)
1. Binding recognition of substrates in NS2B/NS3 serine protease of Zika virus revealed by molecular dynamics simulations. Nutho B; Rungrotmongkol T J Mol Graph Model; 2019 Nov; 92():227-235. PubMed ID: 31401441 [TBL] [Abstract][Full Text] [Related]
2. Substrate profiling of Zika virus NS2B-NS3 protease. Gruba N; Rodriguez Martinez JI; Grzywa R; Wysocka M; Skoreński M; Burmistrz M; Łęcka M; Lesner A; Sieńczyk M; Pyrć K FEBS Lett; 2016 Oct; 590(20):3459-3468. PubMed ID: 27714789 [TBL] [Abstract][Full Text] [Related]
3. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of unlinked NS2B-NS3 protease from Zika virus. Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580 [TBL] [Abstract][Full Text] [Related]
5. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease. Ren J; Lee H; Kotak A; Johnson ME Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176 [TBL] [Abstract][Full Text] [Related]
7. Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs. Ezzemani W; Altawalah H; Windisch M; Ouladlahsen A; Saile R; Kettani A; Ezzikouri S J Biomol Struct Dyn; 2024 Sep; 42(15):8073-8088. PubMed ID: 37528667 [TBL] [Abstract][Full Text] [Related]
8. Structure of the NS2B-NS3 protease from Zika virus after self-cleavage. Phoo WW; Li Y; Zhang Z; Lee MY; Loh YR; Tan YB; Ng EY; Lescar J; Kang C; Luo D Nat Commun; 2016 Nov; 7():13410. PubMed ID: 27845325 [TBL] [Abstract][Full Text] [Related]
9. Exploiting the unique features of Zika and Dengue proteases for inhibitor design. Majerová T; Novotný P; Krýsová E; Konvalinka J Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760 [TBL] [Abstract][Full Text] [Related]
10. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942 [TBL] [Abstract][Full Text] [Related]
11. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity. Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367 [TBL] [Abstract][Full Text] [Related]
19. Structures and dynamics of peptide and peptidomimetic inhibitors bound to the NS2B-NS3 protease of the ZIKA virus. Pant S; Bhattacharya G; Jena NR J Biomol Struct Dyn; 2023 Apr; 41(7):3076-3088. PubMed ID: 35238272 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus. Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]